Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLG Antikörper (HRP)

PLG Reaktivität: Human WB, ELISA, IHC Wirt: Ziege Polyclonal HRP
Produktnummer ABIN5596692
  • Target Alle PLG Antikörper anzeigen
    PLG (Plasminogen (PLG))
    Reaktivität
    • 95
    • 32
    • 29
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 82
    • 14
    • 11
    • 8
    • 1
    Ziege
    Klonalität
    • 109
    • 7
    Polyklonal
    Konjugat
    • 70
    • 17
    • 10
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PLG Antikörper ist konjugiert mit HRP
    Applikation
    • 82
    • 49
    • 27
    • 18
    • 15
    • 14
    • 14
    • 12
    • 12
    • 10
    • 9
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Kreuzreaktivität (Details)
    Cross reactivity against Plasminogen from other sources is unknown.
    Aufreinigung
    Anti-Plasminogen is an IgG fraction antibody purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above. Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Peroxidase, anti-Goat Serum as well as purified and partially purified Plasminogen [Human Plasma].
    Immunogen

    Immunogen: Plasminogen [Human Plasma]

    Immunogen Type: Native Protein

    Isotyp
    IgG
    Top Product
    Discover our top product PLG Primärantikörper
  • Applikationshinweise

    Immunohistochemistry Dilution: 1:250 - 1:1,000

    Application Note: Anti-Plasminogen has been assayed against 1.0 μg of Plasminogen [Human Plasma] in a standard capture ELISA using ABTS (2,2'-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) code # ABTS-100 as a substrate for 30 minutes at room temperature. A working dilution of 1:1,000 to 1:4,000 of the reconstitution concentration is suggested for this product.

    Western Blot Dilution: 1:500 - 1:2,500

    ELISA Dilution: 1:2,000 - 1:10,000

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution

    Reconstitution Volume: 100 μL

    Reconstitution Buffer: Restore with deionized water (or equivalent)

    Konzentration
    1.0 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: 10 mg/mL Bovine Serum Albumin (BSA) - Immunoglobulin and Protease free

    Konservierungsmittel
    Gentamicin sulfate
    Vorsichtsmaßnahmen
    This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Haltbarkeit
    12 months
  • Target
    PLG (Plasminogen (PLG))
    Andere Bezeichnung
    Plasminogen (PLG Produkte)
    Synonyme
    wu:fb70e09 antikoerper, PLG antikoerper, LPA antikoerper, plg antikoerper, Ab1-346 antikoerper, AI649309 antikoerper, Pg antikoerper, plasminogen antikoerper, plg antikoerper, PLG antikoerper, Plg antikoerper
    Hintergrund

    Synonyms: Angiostatin antibody, DKFZp779M0222 antibody, Microplasmin antibody, Plasmin antibody, Plasmin heavy chain A antibody, Plasmin light chain B antibody, PLG antibody

    Background: Plasmin is released as a zymogen called plasminogen (PLG) from the liver into the systemic circulation. Two major glycoforms of plasminogen are present in humans. Type II plasminogen is preferentially recruited to the cell surface over the type I glycoform. Conversely, type I plasminogen appears more readily recruited to blood clots. In circulation, plasminogen adopts a closed, activation resistant conformation. Upon binding to clots, or to the cell surface, plasminogen adopts an open form that can be converted into active plasmin by a variety of enzymes, including tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). Fibrin is a cofactor for plasminogen activation by tissue plasminogen activator. Urokinase plasminogen activator receptor (uPAR) is a cofactor for plasminogen activation by urokinase plasminogen activator. The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Deficiency in plasmin may lead to thrombosis, as clots are not degraded adequately. Plasminogen deficiency in mice leads to defective liver repair, defective wound healing, reproductive abnormalities. In humans, a rare disorder called plasminogen deficiency type I is caused by mutations of the PLG gene and is often manifested by ligneous conjunctivitis.

    Gene Name: PLG

    Gen-ID
    5340
    UniProt
    P00747
    Pathways
    Komplementsystem, Lipid Metabolism
Sie sind hier:
Kundenservice